My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2019-198
CBCC
>
Official Documents
>
2010's
>
2019
>
2019-198
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/30/2019 3:04:20 PM
Creation date
12/2/2019 12:53:16 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
11/19/2019
Control Number
2019-198
Agenda Item Number
15.A.1.
Entity Name
Indian River County Firefighters/Paramedics Association,
Local 2201, I.A.F.F. and Indian River County
Subject
Collective Bargaining Agreement October 1, 2019-September 30, 2022
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
89
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
16.0 Consequences of Refusing a Drug Test <br />16.1 An employee who refusesto submit to a drug test will be subject to discipline, up to and including <br />termination of employment. An employee who provides a diluted sample may, depending upon the <br />circumstances, be deemed to have refused to submit to the drug test. <br />16.2 A job applicant who refuses to submit to a drug test will not be hired. <br />17.0 Actions Following Positive Confirmed Test: <br />17.1 An employee who tests positive on a confirmation test will be immediately suspended without pay, <br />and subject to disciplines up to and including termination. If the problem is correctable, the <br />Emergency Services Director, at his discretion, may allow the employee an opportunity for <br />rehabilitation through a last -chance agreement. Any such last -chance agreement shall include a <br />provision for random drug testing for two (2) years from the date of the agreement, and successful <br />completion of any treatment program recommended by a healthcare professional. The employee shall <br />be responsible, through his insurance or otherwise, for the cost of the random testing and treatment <br />program. Under no circumstances shall an employee be allowed to return to work prior to receiving a <br />negative test result. <br />17.2 Refusal of a last chance agreement: If an employee is offered an opportunity to enter into a last -chance <br />agreement and refuses to do so, the employee will be immediately terminated. <br />17.3 Treatment program requirements: Employees who have been provided with an opportunity to enter <br />into a treatment and/or rehabilitation program as part of a last -chance agreement must meet all <br />requirements of that program including any required aftercare. Failure to follow or complete the <br />treatment and/or rehabilitation program or a subsequent positive confirmed drug test will result in <br />immediate termination of employment. <br />17.4 The employee or job applicant who receives a positive confirmed test result may contest or explain the <br />result to the Medical Review Officer (MRO) within five (5) working days after receiving written <br />notification of the test result. If an employee's or job applicant's explanation or challenge is <br />unsatisfactory to the MRO, the MRO shall report a positive test result back to the employer. The drug <br />test result may be contested pursuant to law or to rules adopted by the ARCA. <br />18.0 Reporting of Use of Medication: Employees and job applicants may confidentially report the use of <br />prescription or non-prescription medication to the MRO through the Emergency Services Director, or his or her <br />designee, both before and after having a drug test. <br />19.0 Notice of Common Medications: A list of the most common medications by brand name or common name, as <br />applicable, as well as chemical name, which may alter or affect a drug test, is attached. Employees and job <br />applicants should review this list prior to submitting to a drug test. <br />20.0 Medication Information: An employee or job applicant may consult with the Employer's MRO or the testing <br />laboratory for technical information regarding prescription and non-prescription medication. <br />77 <br />
The URL can be used to link to this page
Your browser does not support the video tag.